<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> in IBD is the result of a combination of <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> and <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> disease </plain></SENT>
<SENT sid="1" pm="."><plain>Therapy of IBD is relief of <z:mp ids='MP_0001845'>inflammation</z:mp>, but the <z:e sem="disease" ids="C0242510" disease_type="Mental or Behavioral Dysfunction" abbrv="">drugs usage</z:e> may cause the development <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the effect of basic therapy on the incidence of <z:hpo ids='HP_0001903'>anemia</z:hpo> and assess the impact of modern biological therapies on the main markers of AHZ </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 153 patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) and 53 patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD), which at the time of the study received basic anti-inflammatory therapy for at least 1 year </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent blood tests, iron metabolism parameters were determined by the level of erythropoietin and G-gepsidina C reactive protein </plain></SENT>
<SENT sid="5" pm="."><plain>Modern biological therapy increases the effectiveness of the treatment of <z:hpo ids='HP_0001903'>anemia</z:hpo> in patients with IBD </plain></SENT>
<SENT sid="6" pm="."><plain>The use of Remicade gives a quick positive response, which is due to the decrease of gepsidin negative influence on iron metabolism and unlocking the synthesis of erythropoietin </plain></SENT>
<SENT sid="7" pm="."><plain>The use of MSCs does not inhibit the synthesis of erythropoietin, and is likely to stimulate erythropoiesis at the erythroblast precursors </plain></SENT>
</text></document>